Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations

Author(s):
Brohet, R.M.; Velthuizen, M.E.; Hogervorst, F.B.L.; Meijers-Heijboer, H.E.J.; Seynaeve, C.; Collee, M.J.; Verhoef, S.; Ausems, M.G.E.M.; Hoogerbrugge, N.; Asperen, C.J. van (0000-0002-1436-7650); Garcia, E.G.; Menko, F.; Oosterwijk, J.C.; Devilee, P. (0000-0002-8023-2009); van't Veer, L.J.; Leeuwen, F.E. van; Easton, D.F.; Rookus, M.A.; Antoniou, A.C.; HEBON Resource
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-02-28
Language
English
Is part of
Journal of Medical Genetics (2014), Vol. 51, no. 2, p. 98-107
hdl
1887/108302
doi
10.1136/jmedgenet-2013-101974